* This is the Professional Version. *
Cryptosporidiosis is infection with Cryptosporidium. The primary symptom is watery diarrhea, often with other signs of GI distress. Illness is typically self-limited in immunocompetent patients but can be persistent and severe in patients with AIDS. Diagnosis is by identification of the organism or antigen in stool. Treatment of immunocompetent people, when necessary, is with nitazoxanide. For patients with AIDS, highly active antiretroviral therapy and supportive care are used.
Cryptosporidia are coccidian protozoa that replicate in small-bowel epithelial cells of a vertebrate host. Infective oocysts are shed into the lumen and passed in stool. Very few oocysts (eg, <100) are required to cause disease, thus increasing risk of person-to-person transmission. After ingestion by another vertebrate, the oocyst releases sporozoites that transform into trophozoites in intestinal epithelial cells, replicate, and then produce oocysts that are released into the lumen of the intestine to complete the cycle. Thin-walled oocysts are involved in autoinfection.
Oocysts are resistant to harsh conditions, including chlorine at levels usually used in public water treatment systems and swimming pools despite adherence to recommended residual chlorine levels.
Cryptosporidium parvum (bovine genotype) and C. hominis (human genotype) are responsible for most human cases. Infections result from ingestion of fecally contaminated food or water (often water in public and residential pools, hot tubs, water parks, lakes, or streams), direct person-to-person contact, or zoonotic spread.
The disease occurs worldwide. Cryptosporidiosis is responsible for 0.6 to 7.3% of diarrheal illness in developed countries and an even higher percentage in areas with poor sanitation. In Milwaukee, Wisconsin, > 400,000 people were affected during a waterborne outbreak in 1993, when the city’s water supply was contaminated by sewage during spring rains and the filtration system was not working correctly.
Children, travelers to foreign countries, immunocompromised patients, and medical personnel caring for patients with cryptosporidiosis are at increased risk. Outbreaks have occurred in day care centers. The small number of oocysts required to cause infection, the prolonged excretion of oocysts, the resistance of oocysts to chlorination, and their small size raise concern about swimming pools used by diapered children.
Severe, chronic diarrhea due to cryptosporidiosis is a problem in patients with AIDS.
The incubation period is about 1 wk, and clinical illness occurs in > 80% of infected people. Onset is abrupt, with profuse watery diarrhea, abdominal cramping, and, less commonly, nausea, anorexia, fever, and malaise. Symptoms usually persist 1 to 2 wk, rarely ≥ 1 mo, and then abate. Fecal excretion of oocysts may continue for several weeks after symptoms have subsided. Asymptomatic shedding of oocysts is common among older children in developing countries.
In the immunocompromised host, onset may be more gradual, but diarrhea can be more severe. Unless the underlying immune defect is corrected, infection can persist, causing profuse intractable diarrhea for life. Fluid losses of > 5 to 10 L/day have been reported in some AIDS patients. The intestine is the most common site of infection in immunocompromised hosts; however, other organs (eg, biliary tract, pancreas, respiratory tract) may be involved.
Identifying the acid-fast oocysts in stool confirms the diagnosis, but conventional methods of stool examination (ie, routine "stool for ova and parasites" testing) are unreliable. Oocyst excretion is intermittent, and multiple stool samples may be needed. Several concentration techniques increase the yield. Cryptosporidium oocysts can be identified by phase-contrast microscopy or by staining with modified Ziehl-Neelsen or Kinyoun techniques. Immunofluorescence microscopy with fluorescein-labeled monoclonal antibodies allows for greater sensitivity and specificity.
Enzyme immunoassay for fecal Cryptosporidium antigen is more sensitive than microscopic examination for oocysts. DNA-based assays for detection and speciation of C. parvum and C. hominis have been developed. They are available at the Centers for Disease Control and Prevention (CDC) and are likely to become more widely available at diagnostic laboratories in the future. Intestinal biopsy can demonstrate Cryptosporidium within epithelial cells.
In immunocompetent people, cryptosporidiosis is self-limited. For persistent infections, oral nitazoxanide can be used; the recommended doses, given for 3 days, are
In patients with AIDS, immune reconstitution with ART is key. High-dose nitazoxanide (500 to 1000 mg bid) for 14 days has been effective in adults with a CD count > 50/μL. Symptoms have abated after effective ART in some patients. Supportive measures, oral and parenteral rehydration, and hyperalimentation are indicated for immunocompromised patients.
Stools of patients with cryptosporidiosis are highly infectious; strict stool precautions should be observed. Special biosafety guidelines have been developed for handling clinical specimens. Boiling water is the most reliable decontamination method; only filters with pore sizes ≤ 1 μm (specified as “absolute 1 micron” or certified by NSF Standard No. 53) remove Cryptosporidium cysts.
Cryptosporidiosis spreads easily because fecal excretion of oocysts persists for weeks after symptoms resolve, a very small number of oocysts are required for infection, and oocysts are difficult to remove by conventional water filtration and resistant to chlorination.
Profuse, watery diarrhea with cramping is usually self-limited but can be severe and lifelong in patients with AIDS.
Diagnose using enzyme immunoassay for fecal antigen; microscopic stool examination is less accurate and requires specialized techniques.
For people without AIDS, use nitazoxanide.
For people with AIDS, amebicides are ineffective, but symptoms may abate when the immune system improves with ART.
Drug NameSelect Trade
* This is the Professional Version. *